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The LSTRA cell line has been shown to have an exceptionally high level of a tyrosine protein kinase 
(pp56rck). We now report that LSTRA cells also have a much higher level of proteins phosphorylated on 
tyrosine residues in comparison to several other cell lines with normal levels of pp56kk. The level of phospho- 
tyrosine-containing proteins in LSTRA cells was comparable to that seen in K562 cells, a cell line known 
to have a constitutively active tyrosine protein kinase. These results provide evidence that LSTRA cells have 
an elevated level of in vivo tyrosine protein kinase activity, probably due to the overexpression and activa- 
tion of pp56tck. 
Tyrosine protein kinase; Phosphotyrosine antibody; (Lymphoid cell) 
1. INTRODUCTION 
The LSTRA cell line contains an elevated level 
of a tyrosine protein kinase (~~56’~~) with especial- 
ly strong sequence homology with pp60src [l-4]. It 
has been suggested that the elevated level of 
pp561Ck could have a causal role in the transforma- 
tion of LSTRA cells [2,4]. In anaiogy with other 
tyrosine protein kinases such as pp60Src [5,6], a 
transforming role for pp561Ck requires that its 
overexpression results in an increase in the in vivo 
level of tyrosine protein kinase activity in these 
cells. Although it has been conclusively 
demonstrated that pp561Ck is elevated in LSTRA 
cells, it is not known if this results in an increase 
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in the tyrosine phosphorylation of proteins other 
than pp561Ck. This is an important point because 
overexpression of pp60STC fails to result in an in- 
creased level of in vivo tyrosine protein kinase ac- 
tivity since the enzyme is in an inactive form [5,6]. 
We have shown that in LSTRA cells pp561Ck is
phosphorylated in vivo at several sites on tyrosine 
residues [7], one of them being the site of in vitro 
autophosphorylation. This site is identical in se- 
quence to the site of autophosphorylation in 
pp60Src [7]. In pp60’” this site is phosphorylated 
only when pp60STC is in an active form [8]. Given 
the strong sequence homology between pp561Ck and 
pp60src [3,4], it seems likely that in pp561Ck this site 
is also only phosphorylated in catalytically active 
molecules, and therefore LSTRA cells should have 
a high intracellular level of tyrosine protein kinase 
activity. We have previously shown that LSTRA 
cells have a relatively high phosphotyrosine con- 
tent [ 11, and this was interpreted as indicating an 
enhanced level of tyrosine protein kinase activity. 
However, these results could simply reflect the 
elevated level of pp561Ck in these cells since this pro- 
tein is highly phosphorylated on tyrosine residues 
[7]. A more definitive approach to measuring in 
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vivo levels of tyrosine protein kinase activity is 
through the use of antibodies to phosphotyrosine. 
These antibodies permit one to monitor the general 
level of phosphotyrosine-containing proteins in in- 
tact cells and thus obtain a measure of the level of 
in vivo tyrosine protein kinase activity. 
2. EXPERIMENTAL 
Unless otherwise indicated the antibodies to 
phosphotyrosine were prepared using phos- 
photyrosine conjugated to human immuno- 
globulin as the antigen [9,10]. Rabbits were 
initially immunized by injection into the popliteal 
lymph nodes followed by intradermal booster in- 
jections. The antibodies were affinity purified on a 
phosphotyrosine-Sephadex column using 25 mM 
phosphotyrosine to elute the specific antibodies. 
Antibodies were first dialyzed against 3 changes of 
1 1 volumes of phosphate-buffered saline to 
remove the phosphotyrosine and then concen- 
trated to about 10 mg/ml by dialysis against con- 
centrated sucrose. Some experiments were 
performed with phosphotyrosine antibodies 
prepared against the phosphotyrosine-containing 
Abelson protein expressed in bacteria [ 111, kindly 
provided by Dr J.Y. J. Wang (University of 
California at San Diego). Samples were subjected 
to electrophoresis on 7.5% polyacrylamide gels 
followed by transfer to nitrocellulose. Im- 
munoblots were performed as previously described 
with ‘251-labeled protein A being used to detect the 
immune complexes [lo]. Cells were cultured in 
Iscove’s medium supplemented with 10% 
Nuserum (Collaborative Research). Primary 
cultures of interleukin-2-dependent T cells were 
established from PHA stimulated blasts as de- 
scribed in [lo]. 
3. RESULTS 
protein recognized by these antibodies has an Mr of 
56000. We have previously identified this protein 
as pp561Ck [IO]. In addition to pp561ck, the an- 
tibodies recognize several other proteins in LSTRA 
cells, the most prominent ones having approximate 
molecular masses of 160000, 110000, 88000, 
67000 and 47000. 
Initial experiments were aimed at characterizing In fig.lB the blot of LSTRA cells was probed 
the phosphotyrosine-containing proteins in with a preparation of phosphotyrosine antibodies 
LSTRA cells and demonstrating the specificity of made against the Abelson tyrosine protein kinase 
the antibodies. In fig.1 intact LSTRA cells were produced in bacteria [I 11. The pattern of proteins 
dissolved in SDS and subjected to polyacrylamide recognized by these second antibodies was iden- 
electrophoresis followed by blotting to nitro- tical to that obtained with the antibodies made 
cellulose. The blot in fig.lA was probed with against the phosphotyrosine-immunoglobulin con- 
antibodies prepared against phosphotyrosine con- jugates. Since the two antibodies were made using 
jugated to human immunoglobulin. The major different carrier proteins, the only common 
Fig. 1. Pattern of proteins recognized in blots of LSTRA 
cells by antiphosphotyrosine antibodies made against 
phosphotyrosine conjugated to human immunoglobulin 
(A) or made against the phosphotyrosine-containing 
Abelson tyrosine protein kinase produced in bacteria 
(B). For each lane 1 x lo6 cells were applied to the gel 
that was subsequently blotted onto nitrocellulose. 
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Fig.2. Preservation by phosphatase inhibitors of 
proteins recognized in homogenates of LSTRA cells by 
antibodies to phosphotyrosine. Cells were either 
immediately dissolved in electrophoresis ample buffer 
(WHOLE CELLS) or homogenized in 5 mM Hepes, pH 
7.4, 1 mM EDTA, and incubated for 2 h on ice in the 
absence ( - ) or presence ( + ) of 1 mM sodium 
orthovanadate and 5 mM p-nitrophenyl phosphate. 
Material from an equivalent number of cells (1 x 106) 
was loaded onto each lane. 
epitope that they should recognize is the 
phosphotyrosine moiety. Thus, the observation 
that two different antibodies recognize the same 
pattern of proteins provides strong evidence that 
they are recognizing phosphotyrosine residues in 
these proteins and not some cross-reacting but ir- 
relevant epitope. 
Additional control experiments confirmed this 
Fig.3. Autoradiogram of blot of various T cell lines 
probed with antibodies against phosphotyrosine. (1) 
LSTRA cells; (2) Jurkat cells; (3) CCRF-CEM cells; (4) 
2B4 cells; (5) YAC cells; (6) interleukin-2-dependent T 
cells. The arrow indicates ~~56”~. 
conclusion. Premcubation of the antibodies with 
phosphotyrosine completely inhibited their ability 
to detect proteins in LSTRA cells (not shown). 
Fig.2 shows that the proteins detected in the blots 
have another property expected of phosphotyro- 
sine-containing proteins. The phosphotyrosine in 
these proteins should be vulnerable to phosphat- 
ases and undergo dephosphorylation in homogen- 
ates, resulting in the loss of the proteins from the 
blots. Such dephosphorylation should be inhibited 
by phosphotyrosine phosphatase inhibitors. Fig.2 
shows that incubation of homogenates of LSTRA 
cells for 2 h on ice results in the loss of most of the 
proteins recognized by the phosphotyrosine anti- 
bodies. This loss is completely inhibited by the in- 
clusion of the phosphotyrosine phosphatase 
inhibitors [ 121 sodium orthovanadate and p-nitro- 
phenol phosphate. Thus the results from these 
various experiments provide conclusive evidence 
that the proteins identified in the blots are phos- 
phorylated on tyrosine residues. 
106 
Volume 222, number 1 
A 6 
FEBS LETTERS September 1987 
Fig.4. Comparison of the levels of proteins 
phosphorylated on tyrosine residues in K562 (A) and 
LSTRA cells (B). The blots were performed using 1 x 
lo6 cells. This represented approximately twice as much 
protein in the sample of K562 cells as compared to the 
LSTRA cells. The arrowheads in A and B point to the 
positions of ~210“~~’ and pp561Ck, respectively. 
Fig.3 compares the level of phosphotyrosine 
containing proteins in LSTRA cells (lane 1) with 
that in several other T cell lines (lanes 2-5), plus 
normal interleukin-2-dependent T cells (lane 6). 
For this experiment 2 x lo6 cells were solubilized 
and loaded onto the gels. This represented approx- 
imately equal amounts of protein for each cell 
type. In contrast to the blots of LSTRA cells, these 
various other cells have very low levels of 
phosphotyrosine containing proteins. The result in 
fig.3 was obtained with the antibodies made 
against the phosphotyrosine-immunoglobulin con- 
jugate. Similar results were also obtained with the 
antibodies made against the Abelson protein (not 
shown). The observation that the phosphotyrosine 
antibodies detected little or no p56rck in cells other 
than LSTRA is in agreement with results obtained 
with antibodies against a synthetic fragment of 
p561Ck, which showed that these cells have much 
lower levels of pp56rCk in comparison to the 
LSTRA cell line (not shown). 
In order to compare the level of 
phosphotyrosine-containing proteins in LSTRA 
cells with that of a cell line known to have a con- 
stitutively active tyrosine protein kinase, a blot was 
performed comparing LSTRA cells with K562 
cells. The K562 cells are a nonadherent, 
hematopoietic line that have an elevated level of 
tyrosine protein kinase activity due to the expres- 
sion of an aberrant, catalytically active form of the 
Abelson tyrosine protein kinase [13]. Previous 
workers have shown that this high level of in vivo 
tyrosine protein kinase activity causes the K562 
cells to have a much higher level of 
phosphotyrosine-containing proteins in com- 
parison to other cell ines [14]. As shown in fig.4, 
while the two cell lines have only a few 
phosphotyrosine-containing proteins in common, 
it is apparent that the overall level of 
phosphotyrosine-containing proteins in LSTRA 
cells is comparable to, if not greater than the level 
in K562 cells. 
4. DISCUSSION 
This work demonstrates that the LSTRA cell 
line has a much higher level of proteins 
phosphorylated on tyrosine residues than other T 
cell lines. The level of proteins phosphorylated on 
tyrosine residues in LSTRA cells was comparable 
to that seen in a cell line that is known to have a 
constitutively active tyrosine protein kinase. Thus, 
the regulation of protein tyrosine phosphorylation 
in the LSTRA cells is clearly abnormal. It is possi- 
ble that these proteins are all constitutively 
phosphorylated on tyrosine residues and it is their 
protein levels that are increased in LSTRA cells 
and not their relative phosphotyrosine content. 
However, in a large number of other studies, con- 
stitutively enhanced levels of proteins phos- 
phorylated on tyrosine residues have been shown 
to be due to the presence of an activated tyrosine 
protein kinase, such as in the case of the K562 
cells. Thus, the most likely interpretation of the 
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results reported in this paper is that the LSTRA 
cell line also has a constitutively activated tyrosine 
protein kinase. The most probable candidate for 
this active enzyme is pp561ck, since this protein is 
greatly elevated in this cell line and the results of 
analyzing the sites of in vivo phosphorylation of 
~~56”~ in LSTRA cells indicated that some portion 
of pp561Ck is in an active state [7]. These results are 
especially interesting in light of the fact that 
overexpression of pp60src does not lead to an active 
enzyme. It would thus appear that not only is 
~~56”~ overexpressed in LSTRA cells, but it must 
also be receiving a constant activating signal that 
results in the elevated level of in vivo activity. Fur- 
ther studies on pp561Ck in LSTRA cells should lead 
to a better understanding of the factors regulating 
its activity. The presence of numerous 
phosphotyrosine-containing proteins in LSTRA 
cells indicates that this cell line should be extremely 
useful for identifying substrates for tyrosine pro- 
tein kinases in lymphoid cells. 
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